Page last updated: 2024-10-25

cimetidine and Adenohypophyseal Diseases

cimetidine has been researched along with Adenohypophyseal Diseases in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
García Centenera, JA1
Requejo, F1
Alba, JP1
Herrán, M1
Lucero, JL1
Vilchez, JM1
Hervás, F1

Trials

1 trial available for cimetidine and Adenohypophyseal Diseases

ArticleYear
[H2-receptors and prolactin secretion. Effects of acute and chronic administration of cimetidine on subjects with normal and high levels of prolactin (author's transl)].
    Medicina clinica, 1980, Jan-10, Volume: 74, Issue:1

    Topics: Adult; Cimetidine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Guanidines; Humans; I

1980